Objective To study the optimal formula and preparation for Potassium Citrate Sustained Release Tablet.
目的研究柠檬酸钾缓释片的最佳处方和制备工艺。
Nicotinic acid sustained release tablet was prepared and its releasing features in vitro were evaluated.
制备烟酸缓释片剂，并评价其体外释放特性。
Objective: To compare the pharmacokinetics and relative bioavailability between matrine sustained release tablet, matrine conventional capsule and matrine injection.
目的：比较苦参碱缓释片、苦参碱普通胶囊和苦参碱注射液的药代动力学及生物利用度。
CONCLUSION: The two formulations were bioequivalent and the sustained release tablet showed smaller difference between C max and C min and smaller DF compared with the ordinary tablet.
结论：两种制剂具生物等效性，且缓释片比常释片有峰谷浓度差异小、血药浓度波动幅度小的特点。
The new preparation is sustained-release tablet releasing medicaments slowly and inconstantly in a provided release medium.
该新剂型的特征在于本品为缓释片，在规定的释放介质中缓慢的非恒速的释放药物。
OBJECTIVE To prepare sustained-release Hippophae rhamnoides(TFH) tablet and evaluate the rule of drug release property.
目的评价醋柳黄酮缓释片的缓释效果并考察其体外释放规律。
CONCLUSION The TFH tablet has sustained release property in vitro. The drug release pattern is in accord with Weibull distribution.
结论醋柳黄酮缓释片缓释效果显著，体外释放符合威布尔分布模型。
Objective: To study the quality specification of Gliclazide Sustained-release Tablet.
目的：对格列齐特缓释片进行质量标准研究。
METHODS To prepare sustained release pellets using fluid bed, then to get pulsatile-sustained tablet after tabletting and coating.
方法采用流化床包衣法制得缓释微丸，将微丸压片后包衣制得时控脉冲缓释片。
Objective To screen out an optimum pharmaceutical formulation of intra-gastric floating sustained-release tablet of Zuojin Pills (IFTZ).
目的优选左金丸胃内漂浮缓释片的制剂配方。
OBJECTIVE: To prepare sustained-release famotidine tablet and evaluate its drug release property.
目的：制备法莫替丁缓释片剂，并评价其释放特性。
OBJECTIVE To investigate the release property of sustained-release sodium fluoride tablet.
目的研究氟化钠缓释片的释放特性。
OBJECTIVE: To study the application of the spherical symmetric design in the optimization of the roxatidine sustained-release tablet and to study its releasability.
目的研究球面对称设计法在缓释片处方优化中的应用并考察其释放度。
To optimize the formula of the double-layer tablet of nateglinide rapid-release layer and metformin hydrochloride sustained-release layer.
优选由那格列奈速释层与盐酸二甲双胍缓释层组成的双层片处方。
The preparation is a sustained-release tablet containing mecobalamin.
该制剂是含有甲钴胺的缓释片剂。
Sustained-release tablet (S) and ordinary tablet (0) of Li2CO3 were used to treat mania, 95 patients in each group. The response rates in groups S and O were statistically significant(P<0.01).
比较碳酸锂缓释片与普通片治疗躁狂症各95例的疗效，结果前组有效率显著高于后组（P<0.01）。
Methods The preparation formulation of the sustained-release tablet was optimized by orthogonal design which took the released rate as the index.
方法以大蒜油中有效成分大蒜素的释放度为指标，采用正交设计法优化缓释片的制剂处方工艺。
The effect of some factors on the drug release from the HPMC sustained-release matrix tablet was investigated.
考察了影响多索茶碱缓释骨架片释药的因素。
CONCLUSION HPMC could be used as a matrix to prepare sustained-release tablet of ambroxol hydrochloride.
结论用羟丙甲基纤维素作为骨架材料能达到较好的缓释作用。
OBJECTIVE:To compare the concentration in gingival crevicular fluid between metronidazole tablet and sustained-release film.
目的：比较甲硝唑片及其缓释药膜在龈沟液中的浓度，以了解其用药差别。
OBJECTIVE to prepare bilayer tablet, which consists of a metoclopramide rapid release layer and a naproxen sodium sustained release layer.
目的制备由甲氧氯普胺速释层与萘普生钠缓释层组成的双层片。
RESULTS:The dose of sustained-release film was 1/400 of tablet, and the concentration in gingival crevicular fluid was 60 times.
结果：缓释药膜的用量是片剂的1/400，而龈沟液中甲硝唑的浓度是片剂的60倍。
Conclusion HPMCK 4m could be used as a matrix to prepare sustained-release tablet of nicotinic acid.
结论用羟丙甲基纤维素作为骨架材料能达到较好的缓释作用。
Conclusion HPMCK 4m could be used as a matrix to prepare sustained-release tablet of nicotinic acid.
结论用羟丙甲基纤维素作为骨架材料能达到较好的缓释作用。
应用推荐